Possible application of melatonin treatment in human diseases of the biliary tract

Am J Physiol Gastrointest Liver Physiol. 2019 Nov 1;317(5):G651-G660. doi: 10.1152/ajpgi.00110.2019. Epub 2019 Sep 11.

Abstract

Melatonin was discovered in 1958 by Aaron Lerner. Its name comes from the ability of melatonin to change the shape of amphibian melanophores from stellate to roundish. Starting from the 1980s, the role of melatonin in the regulation of mammalian circadian and seasonal clocks has been elucidated. Presently, several other effects have been identified in different organs. For example, the beneficial effects of melatonin in models of liver damage have been described. This review gives first a general background on experimental and clinical data on the use of melatonin in liver damage. The second part of the review focuses on the findings related to the role of melatonin in biliary functions, suggesting a possible use of melatonin therapy in human diseases of the biliary tree.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Animals
  • Antioxidants / therapeutic use
  • Biliary Tract Diseases / drug therapy*
  • Biliary Tract Diseases / etiology
  • Biliary Tract Diseases / metabolism
  • Central Nervous System Depressants / therapeutic use
  • Humans
  • Liver Diseases / drug therapy*
  • Liver Diseases / etiology
  • Liver Diseases / metabolism
  • Melatonin / metabolism*
  • Melatonin / therapeutic use

Substances

  • Antioxidants
  • Central Nervous System Depressants
  • Melatonin